Engineering the Future of Longevity R&D: The Case for AI-Driven, Integrated Biotechnology Ecosystems

Dec 16, 2025Aging and disease

Using AI and connected biotech systems to advance aging research

AI simplified

Longevity & Aging on OpenScience ↗PubMed ↗DOI ↗

Abstract

The AI-Integrated Biotechnology Hub proposes a new paradigm for drug discovery and health research.

The hub combines residential, commercial, clinical, and research facilities under a single AI-driven system.
It integrates health data collection and smart living environments to support biomedical research.
The model aims to enhance data utility and accelerate drug discovery efforts.
Governance relies on transparency and ethical stewardship through mechanisms like dynamic consent and data trusts.
It is designed to be scalable in urban and vertical settings, potentially optimizing research workflows.

AI simplified

The escalating cost, extended timelines, and low success rates in pharmaceutical research demand a rethinking of biotechnology R&D infrastructure to more efficiently discover and deliver novel therapeutics to an increasingly aging population. We introduce the concept of the AI-Integrated Biotechnology Hub, a purpose-built research ecosystem uniting residential, commercial, clinical, and research facilities under a central, AI-driven operating system. The hub functions as a multi-sided platform that unites health data collection, smart living environments, and federated learning to enable secure, privacy-preserving biomedical and longevity research. By integrating real estate, biotechnology facilities, research hospitals, and community services, the model maximizes data utility, accelerates drug discovery, and enhances resident well-being. Transparency, accountability, and ethical stewardship are critical pillars of governance, enacted through dynamic consent, data trusts, and multi-stakeholder oversight. Designed to be scalable across urban and vertical architectures, this paradigm represents a potential approach that may enable more efficient research workflows to improve healthspan, foster innovation, and reshape the economics of global drug development.

Engineering the Future of Longevity R&D: The Case for AI-Driven, Integrated Biotechnology Ecosystems

Abstract

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief

Abstract

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief